Forum Rathenau

Product • Innovation

CarboNano.EU: FLTMC Finalist

CarboNano.EU is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

FEINST: FLTMC Finalist

FEINST (Field Enhanced Instrument) is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

Chemistry.Tools: FLTMC Finalist

Chemistry.Tools is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

Exaere: FLTMC Finalist

Exaere is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

MDPath: FLTMC Finalist

MDPath is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

NextLayer: FLTMC Finalist Profile

NextLayer is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

ASAP Research Automation: FLTMC Finalist

ASAP Research Automation is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

ReduCO₂: FLTMC Finalist

ReduCO₂ is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

Microfluidic Standards: FLTMC Finalist

Microfluidic Standards is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

ESILIB: FLTMC Finalist

ESILIB is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

IsoSphere Technologies: FLTMC Finalist Profile

IsoSphere Technologies is one of the finalists for the From Lab to Market Challenge.

Product • Innovation

Snew: FLTMC Finalist

Snew is one of the finalists for the From Lab to Market Challenge.

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.